229 related articles for article (PubMed ID: 25832928)
1. Lifestyle factors and efficacy of lifestyle interventions in gastroesophageal reflux disease patients with functional dyspepsia: primary care perspectives from the LEGEND study.
Haruma K; Kinoshita Y; Sakamoto S; Sanada K; Hiroi S; Miwa H
Intern Med; 2015; 54(7):695-701. PubMed ID: 25832928
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.
Kinoshita Y; Miwa H; Sanada K; Miyata K; Haruma K
J Gastroenterol; 2014 Apr; 49(4):628-37. PubMed ID: 23653056
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients.
Kusano M; Shimoyama Y; Kawamura O; Maeda M; Kuribayashi S; Nagoshi A; Zai H; Moki F; Horikoshi T; Toki M; Sugimoto S; Mori M
Dig Dis Sci; 2007 Jul; 52(7):1673-7. PubMed ID: 17385034
[TBL] [Abstract][Full Text] [Related]
5. Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia.
Miwa H; Haruma K; Sakamoto S; Sanada K; Hiroi S; Kinoshita Y
J Gastroenterol Hepatol; 2015 May; 30(5):834-41. PubMed ID: 25559435
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
Nakada K; Matsuhashi N; Iwakiri K; Oshio A; Joh T; Higuchi K; Haruma K
World J Gastroenterol; 2017 Jul; 23(28):5216-5228. PubMed ID: 28811716
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group.
do Rosário Dias de Oliveira Latorre M; Medeiros da Silva A; Chinzon D; Eisig JN; Dias-Bastos TR
World J Gastroenterol; 2014 Dec; 20(46):17388-98. PubMed ID: 25516650
[TBL] [Abstract][Full Text] [Related]
8. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
Isshi K; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Ogawa M; Arihiro S; Haruma K; Nakada K
J Gastroenterol; 2019 Jun; 54(6):492-500. PubMed ID: 30673836
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
[TBL] [Abstract][Full Text] [Related]
11. Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy.
Nakada K; Oshio A; Matsuhashi N; Iwakiri K; Kamiya T; Manabe N; Joh T; Higuchi K; Haruma K
Esophagus; 2023 Apr; 20(2):309-316. PubMed ID: 36251168
[TBL] [Abstract][Full Text] [Related]
12. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
[TBL] [Abstract][Full Text] [Related]
13. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
14. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
[TBL] [Abstract][Full Text] [Related]
15. Dyspepsia and gastroesophageal reflux disease (GERD): is there any correlation?
Simadibrata M
Acta Med Indones; 2009 Oct; 41(4):222-7. PubMed ID: 20737754
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
Matsuhashi N; Kudo M; Yoshida N; Murakami K; Kato M; Sanuki T; Oshio A; Joh T; Higuchi K; Haruma K; Nakada K
J Gastroenterol; 2015 Dec; 50(12):1173-83. PubMed ID: 25851931
[TBL] [Abstract][Full Text] [Related]
17. Effects of coexisting upper gastrointestinal symptoms on daily life and quality of life in patients with gastroesophageal reflux disease symptoms.
Isshi K; Furuhashi H; Koizumi A; Nakada K
Esophagus; 2021 Jul; 18(3):684-692. PubMed ID: 33389239
[TBL] [Abstract][Full Text] [Related]
18. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
[TBL] [Abstract][Full Text] [Related]
19. Patient selection for therapy reduction after long-term daily proton pump inhibitor treatment for gastro-oesophageal reflux disease: trial and error.
van der Velden AW; de Wit NJ; Quartero AO; Grobbee DE; Numans ME
Digestion; 2013; 87(2):85-90. PubMed ID: 23364219
[TBL] [Abstract][Full Text] [Related]
20. Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.
Hsu CS; Wen SH; Hung JS; Liu TT; Yi CH; Lei WY; Pace F; Chen CL
Dig Dis Sci; 2017 Apr; 62(4):994-1001. PubMed ID: 28116594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
